These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11419742)

  • 1. Simultaneous determination of the histamine H1-receptor antagonist ebastine and its two metabolites, carebastine and hydroxyebastine, in human plasma using high-performance liquid chromatography.
    Matsuda M; Mizuki Y; Terauchi Y
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(1):173-9. PubMed ID: 11419742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of ebastine and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry.
    Kang W; Liu KH; Ryu JY; Shin JG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):75-80. PubMed ID: 15556518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a rapid and selective method for the simultaneous determination of carebastine and pseudoephedrine in human plasma by liquid chromatography-electrospray mass spectrometry for bioequivalence study in Korean subjects.
    Lee MJ; Lee HW; Kang JM; Seo JH; Tak SK; Shim W; Yim SV; Hong SJ; Lee KT
    Biomed Chromatogr; 2010 Oct; 24(10):1031-7. PubMed ID: 20099369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method development and validation for simultaneous determination of ebastine and its active metabolite carebastine in human plasma by liquid chromatography-tandem mass spectrometry and its application to a clinical pharmacokinetic study in healthy Chinese volunteers.
    Phiri M; Li D; Li T; Ji S; Ling T; Li X; Gao H; Ding L; Shu C
    Biomed Chromatogr; 2020 Oct; 34(10):e4904. PubMed ID: 32449558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A.
    Liu KH; Kim MG; Lee DJ; Yoon YJ; Kim MJ; Shon JH; Choi CS; Choi YK; Desta Z; Shin JG
    Drug Metab Dispos; 2006 Nov; 34(11):1793-7. PubMed ID: 16896065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M; Sakashita M; Mizuki Y; Yamaguchi T; Fujii T; Sekine Y
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
    Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T
    Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine.
    Mattila MJ; Aranko K; Kuitunen T
    Br J Clin Pharmacol; 1993 Mar; 35(3):272-7. PubMed ID: 8097102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.
    Van Rooij J; Schoemaker HC; Bruno R; Reinhoudt JF; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Jun; 35(6):661-3. PubMed ID: 8101096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and electrocardiographic effect of ebastine in young versus elderly healthy subjects.
    Huang MY; Argenti D; Wilson J; Garcia J; Heald D
    Am J Ther; 1998 May; 5(3):153-8. PubMed ID: 10099053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of a novel anti-psychotic agent AD-5423 and its metabolites in plasma by high-performance liquid chromatography with fluorescence detection.
    Matsuda M; Sakashita M; Yamaguchi T; Fujii T
    J Pharm Biomed Anal; 1997 Jun; 15(9-10):1449-56. PubMed ID: 9226575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
    Vincent J; Liminana R; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1988 Nov; 26(5):497-502. PubMed ID: 2905150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the first-pass metabolism of ebastine in rats.
    Fujii T; Matsumoto S; Hatoyama T; Miyazaki H
    Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration.
    Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Fujii T; Komemushi S; Itoh M; Sasaki H; Watanabe T; Yanai K
    Br J Clin Pharmacol; 2002 Mar; 53(3):296-304. PubMed ID: 11874393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial pharmacokinetics of ebastine, a substrate for cytochrome P450 2J, in rat isolated heart.
    Kang W; Elitzer S; Noh K; Bednarek T; Weiss M
    Br J Pharmacol; 2011 Aug; 163(8):1733-9. PubMed ID: 21410688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.
    Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Iwata R; Fujii T; Komemushi S; Ido T; Itoh M; Sasaki H; Watanabe T; Yanai K
    Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Optimal mixture design optimization of an HPLC method for simultaneous determination of commonly used antihistaminic parent molecules and their active metabolites in human serum and urine.
    Kanthiah S; Kannappan V
    Biomed Chromatogr; 2017 Aug; 31(8):. PubMed ID: 28058761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations.
    Schmidt AH; Molnár I
    J Pharm Biomed Anal; 2013 May; 78-79():65-74. PubMed ID: 23454599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.